Browsing by Author "Silva, R"
Now showing 1 - 10 of 29
Results Per Page
Sort Options
- 18F-FDG-PET/CT in diagnosis of Q fever endocarditisPublication . Domingues, CM; Ferreira, MJ; Silva, R; Gonçalves, V; Silva, AM; Gonçalves, L
- Antiangiogénicos na Degenerescência Macular Relacionada com a Idade: a medicina baseada na evidência e a utilização off-labelPublication . Faria de Abreu, JR; Silva, R; Cachulo, ML; Figueira, J; Pires, I; Fonseca, P; Murta, JN
- Between autism and schizophreniaPublication . Fontes, H; Furet, A; Araújo, C; Silva, R
- Dependência de nicotina e psicopatologia – o ovo ou a galinha?Publication . Araújo, C; Ferreira Leite, V; Silva, R; Laureano, M
- Doença de Addison em associação com tuberculose pulmonar: a propósito de uma caso clínicoPublication . Silva, R; Marques, M; Fonseca, I; Ferrão, J; Saldanha, MH
- Hiperparatiroidismo primário por carcinoma das paratiróidesPublication . Méndez, M; Silva, R; Devesa, N; Grade, MJ; Vieira, JD; Alexandrino, MB; Moura, JA
- Incidental Detection of 18F-FDG Thyroid Uptake: The Risk of MalignancyPublication . Correia, J; Lapa, P; Albuquerque, A; Macedo, R; Silva, R; Fernandes, H; Costa, G; Pedroso de Lima, J
- Intravitreal anti-VEGF therapy for choroidal neovascularisation secondary to pathological myopia: 4-year outcomePublication . Ruiz-Moreno, JM; Arias, L; Montero, JA; Carneiro, A; Silva, ROBJECTIVE: To report the visual outcome after 4-year follow-up in a series of highly myopic eyes with choroidal neovascularisation (CNV) treated with antivascular endothelial growth factor (anti-VEGF) drugs. METHODS: A retrospective, non-randomised, multicentre, consecutive, interventional case series study was performed. 92 highly myopic eyes with subfoveal CNV were treated with intravitreal injection (IVI) of anti-VEGF. The initial protocol (1 vs 3 injections) was dictated by surgeons' preferences and followed by an as-needed monthly regime. Best-corrected visual acuity (BCVA) was evaluated at baseline and then monthly. The primary aim was to analyse BCVA changes. The effect of age, spherical equivalent (SE) and treating drug were evaluated as secondary objectives. RESULTS: The mean age of the patients was 57 years (SD 14, range 30-93). The mean number of letters read was 46.1 (SD 16.8, range 5-70) at baseline, 55.5 (SD 18.6, range 10-85) at 12 months, 50.1 (SD 20.1, range 5-82) at 24 months, 54.2 (SD 21.9, range 2-85) at 36 months and 53.1 (SD 22.5, range 1-83) at 48 months (p=0.000, initial vs 12, 24 and 36 months; p=0.01 initial vs 48 months; Student t test for paired data). The mean total number of IVI was 4.9 (SD 5.4, range 1-29). SE and treating drug had no influence on the final visual outcome and number of injections required. CONCLUSIONS: Intravitreal bevacizumab and ranibizumab are effective therapies and show similar clinical effects in highly myopic CNV. Visual acuity gain is maintained at 4-year follow-up.
- Left ventricular aneurysms: early and long-term results of two types of repairPublication . Antunes, PE; Silva, R; Oliveira, FJ; Antunes, MJOBJECTIVE: Controversy still exists regarding the optimal surgical technique for postinfarction left ventricular (LV) aneurysm repair. We analyze the efficacy of two established techniques, linear vs. patch remodeling, for repair of dyskinetic LV aneurysms. METHODS: Between May 1988 and December 2001, 110 consecutive patients underwent repair of LV aneurysms. These represent 2.0% of a total group of 5429 patients who underwent isolated CABG during the period. Seventy-six (69.1%) patients were submitted to linear repair and 34 (30.9%) to patch remodelling. There were 94 (84.5%) men and 17 women, with a mean age of 59.2+/-9.2 years. Coronary surgery was performed in all patients (mean no. of grafts/patient, 2.7+/-0.8) and 14 (12.7%) had associated coronary endarterectomy. Forty-four (40.0%) patients had angina CCS class III/IV (linear 43.4%, patch 32.4%, NS) and the majority was in NYHA class I/II (88.2% in both groups). Left ventricular dysfunction (EF>40%) was present in 72 (65.5%) patients (linear 61.8%, patch 73.5%, NS). RESULTS: There was no perioperative mortality, and major morbidity was not significantly different between linear repair and patch repair groups. During a mean follow-up of 7.3+/-3.4 years (range 4-182 months) 14 patients (14.3%) had died, 12 (85.7%) of possible cardiac-related cause. Actual global survival rate was 85.7%. Actuarial survival rates at 5, 10 and 15 years were 91.3, 81.4 and 74%, respectively. There was no significant difference in late survival between the patch and the linear groups. At late follow-up the mean angina and NYHA class were, 1.3 (preoperative 2.4, P<0.001) and 1.5 (preoperative 1.7, NS), respectively, with no difference between the groups. There was no significant difference in hospital readmissions for cardiac causes (linear 22.8% and patch 37.0%). CONCLUSIONS: The technique of repair of postinfarction dyskinetic LV aneurysms should be adapted in each patient to the cavity size and shape, and the dimension of the scar. Both techniques achieved good results with respect to perioperative mortality, late functional status and survival
- A link between asthenia, pallor, and jaundicePublication . Tavares, J; Eugénio, G; Calretas, S; Silva, R; Santos, R; Carvalho, A
- «
- 1 (current)
- 2
- 3
- »